Manyo Factory Co., Ltd (KOSDAQ:439090)
15,000
+200 (1.35%)
At close: Oct 21, 2026
Manyo Factory Revenue
Manyo Factory had revenue of 25.81B KRW in the quarter ending June 30, 2026, a decrease of -18.56%. This brings the company's total for the last twelve months to 107.18B, down -9.81% year-over-year. In the year 2025, Manyo Factory had annual revenue of 113.02B, down -11.65%. That makes Manyo Factory the 24,301st largest company in the world by revenue and 1,402nd in South Korea.
Revenue (ttm)
107.18B
Revenue Growth
-9.81%
P/S Ratio
2.29
Revenue / Employee
1.20B
Employees
89
Market Cap
245.90B
Revenue by Geography
- South Korea 45.26B 40.0%
- Asia 39.63B 35.1%
- North America 16.33B 14.4%
- Other 11.80B 10.4%
Fiscal year ended Dec 31, 2025 See the full Manyo Factory breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 113.02B | -14.90B | -11.65% |
| Dec 31, 2024 | 127.92B | 22.92B | 21.83% |
| Dec 31, 2023 | 105.00B | 3.17B | 3.11% |
| Dec 31, 2022 | 101.84B | 39.22B | 62.62% |
| Dec 31, 2021 | 62.62B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cosmecca Korea | 772.05B |
| CLIO Cosmetics Co.,Ltd | 329.59B |
| C&C International | 292.76B |
| Organic Tea Cosmetics Holdings Company | 228.17B |
| Englewood Lab | 218.19B |
| Icure Pharmaceutical Incorporation | 114.43B |
| Genic | 114.29B |
| BBIA Co., Ltd. | 77.16B |